The first experience with Angiovit in the combination treatment of acute COVID-19 infection

The first experience with Angiovit in the combination treatment of acute COVID-19 infection

On March 11, 2020, the WHO announced the COVID-19 outbreak a pandemic. The disease was established to be caused by a new singlestranded RNA virus (ss-RNA, 29903 bp) that belongs to a group of coronaviruses (CoV).Objective: to assess the results of a pilot analysis of the efficiency of using Angiovit...

Full description

Bibliographic Details
Main Authors: A. N. Boyko, N. A. Shamalov, O. V. Boyko, E. E. Arinina, O. V. Lyang, E. A. Dubchenko, A. V. Ivanov, A. A. Kubatiev
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-06-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
covid-19
treatment
angiitis
folic acid
Online Access:https://nnp.ima-press.net/nnp/article/view/1363

Similar Items

Similar Items